Cancer therapeutics through an evolutionary lens.
作者信息
Swanton Charles
机构信息
Francis Crick Institute, UCL Hospitals and UCL Cancer Institute, Midland Road, London NW1 1AT, UK.
出版信息
J R Soc Med. 2018 Jan;111(1):8-14. doi: 10.1177/0141076817742096.
Abstract
摘要
相似文献
1
Cancer therapeutics through an evolutionary lens.从进化视角看癌症治疗
J R Soc Med. 2018 Jan;111(1):8-14. doi: 10.1177/0141076817742096.
2
Chromosomal Instability in Tumor Initiation and Development.染色体不稳定性在肿瘤起始和发展中的作用。
Cancer Res. 2019 Aug 15;79(16):3995-4002. doi: 10.1158/0008-5472.CAN-18-3235. Epub 2019 Jul 26.
3
Chromosomal instability and aneuploidy as causes of cancer drug resistance.染色体不稳定和非整倍体作为癌症耐药性的成因。
Trends Cancer. 2022 Jan;8(1):43-53. doi: 10.1016/j.trecan.2021.09.002. Epub 2021 Sep 28.
4
Cancer evolution: from Darwin to the Extended Evolutionary Synthesis.癌症进化：从达尔文到扩展进化综合论
Trends Cancer. 2025 Mar;11(3):204-215. doi: 10.1016/j.trecan.2025.01.001. Epub 2025 Jan 28.
5
Aneuploidy approaching a perfect score in predicting and preventing cancer: highlights from a conference held in Oakland, CA in January, 2004.非整倍体在预测和预防癌症方面近乎完美：2004年1月于加利福尼亚州奥克兰市召开的一次会议要点
Cell Cycle. 2004 Jun;3(6):823-8. Epub 2004 Jun 20.
6
Targeting cancer cells by exploiting karyotypic complexity and chromosomal instability.通过利用核型复杂性和染色体不稳定性来靶向癌细胞。
Cell Cycle. 2005 May;4(5):679-82. doi: 10.4161/cc.4.5.1687. Epub 2005 May 25.
7
Biology: Three known unknowns.生物学：三个已知的未知因素。
Nature. 2014 May 29;509(7502):S69-71. doi: 10.1038/509S69a.
8
Targeting karyotypic complexity and chromosomal instability of cancer cells.针对癌细胞的核型复杂性和染色体不稳定性。
Curr Drug Targets. 2010 Oct;11(10):1341-50. doi: 10.2174/1389450111007011341.
9
Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.肿瘤异质性和药物耐药性：通过功能基因组学实现癌症个体化医学。
Biochem Pharmacol. 2012 Apr 15;83(8):1013-20. doi: 10.1016/j.bcp.2011.12.008. Epub 2011 Dec 16.
10
The emergence of resistance to targeted cancer therapeutics.对癌症靶向治疗药物耐药性的出现。
Pharmacogenomics. 2002 Sep;3(5):603-23. doi: 10.1517/14622416.3.5.603.
引用本文的文献
1
The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma-Association with Clinical Outcome and Tumor Phenotypes.转移性黑色素瘤中异质性B-raf V600E突变定量蛋白表达的隐藏故事——与临床结局和肿瘤表型的关联
Cancers (Basel). 2019 Dec 9;11(12):1981. doi: 10.3390/cancers11121981.
2
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients.在黑色素瘤患者的转移灶中发现了人类基因组编码的新型功能蛋白。
Cell Biol Toxicol. 2020 Jun;36(3):261-272. doi: 10.1007/s10565-019-09494-4. Epub 2019 Oct 10.
3
Precision medicine and monoclonal antibodies: breach of promise?精准医学与单克隆抗体：承诺破灭？
Croat Med J. 2019 Jun 13;60(3):284-289. doi: 10.3325/cmj.2019.60.284.
4
The seductive hope of cancer therapies.癌症治疗的诱人希望。
J R Soc Med. 2018 Oct;111(10):343. doi: 10.1177/0141076818807039.
5
Imagine ... a better future for the NHS.想象一下……国民保健制度的更美好未来。
J R Soc Med. 2018 Jan;111(1):3. doi: 10.1177/0141076817752888.
Zotero 插件